CClinicalTrials.gg
Status unknownNCT04608695Updated Sep 21, 2022

Ovarian Needle Puncture for Follicle Activation in IVF Patients With Diminished Ovarian Reserve

An interventional study of Ovarian puncture in Activation of Primordial Follicles, sponsored by Hacettepe University. Status unknown at 1 site in Turkey. Open to female participants aged Up to 40 Years. Per ClinicalTrials.gov, last updated 2022-09-21.

Sponsored by Hacettepe University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2022), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2020, registered Oct 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Non-randomized
Ages
Up to 40 Years
Sex
Female
01

Study summary

Premature ovarian insufficiency (POI), is cessation of ovarian function characterized by hypergonadotropic amenorrhea and hypoestrogenic syndrome before 40 years of age. About 1% of women younger than 40 years old and 0.1% before 30 are affected. POI imposes a great challenge on women's reproductive and long-term health, such as infertility, amenorrhea, osteoporosis, and cardiovascular disease. Most patients already had impaired or complete loss of fecundity when diagnosed. Currently, no optimal regimen exists to ameliorate ovarian function. Typically, they end up with egg donation or adoption as an alternative way. Less severe form of POI is diminished ovarian reserve (DOR). Although lack of consensus according to Bologna criteria cut off for DOR was defined as (antral follicle count (AFC) \<5-7 follicles or anti-Mullerian hormone (AMH) \<0.5-1.1 ng/ml).

Previously it has been showed that 24% of women with POI had resumption of ovarian function and 4% resulted in baby births. These data indicates residual follicles are available in atrophic ovaries and have potential for development and even fertilization. In routine IVF practice 15% percent of patients have poor ovarian response to ovarian stimulation. Patients with DOR with a previous poor ovarian response (cycles cancelled or yielding ≤3 oocytes with a conventional protocol) might have benefit from the strategies increasing follicle activation and number of growing follicles and oocyte retrieved. Therefore, strategies enabling ovarian resumption predictable and follicle activation feasible are promising for POI/DOR treatment. Recently, In vitro Activation (IVA) approach has been proposed and live births have been achieved in patients with POI. Phosphatase and tensin homolog (PTEN) enzyme inhibitors and phosphatidylinositol-3 kinase activators could activate AKT pathway and activate the dormant follicles. Ovarian fragmentation could lead to ovarian primary follicle growth by interfering with Hippo signaling pathway. Residual follicles in patients with POI could be activated to develop for egg retrieval by combination of mechanical and chemical stimulation.

In 2019, Zhang et al retrospectively analyzed the follicle development and pregnancy outcome in 80 POI patients after laparoscopic ovarian biopsy/scratch without using chemical agents as was the case in IVA. 11 (13.75%) patients presented with ovarian function resumption, three metaphases II oocytes were retrieved in 10 patients and two embryos were formed and freshly transferred followed by a healthy singleton delivery in 1 (1.25%) patient. They concluded that the technique of ovarian biopsy/scratch without chemical activation could promote follicle development in vivo, suggesting it could bring promising benefits for some women with POI.

In patient with POI/DOR, activation of residual follicles is a promising option and further studies are warranted. Previous studies included laparoscopic surgery which may lead to possible surgical complications. Without using chemical agents and laparoscopic surgery, main object of this study is mechanical follicle activation with trans-vaginal ovarian needle puncture with 17 gauge oocyte pickup needle in IVF patients with DOR.

02

Conditions studied

  • Activation of Primordial Follicles

Keywords

  • Follicle Activation
  • Premature Ovarian Insufficiency
  • Diminished Ovarian Reserve
  • Ovarian Puncture
03

In context

Lead sponsor

Hacettepe University is the lead sponsor of 983 studies on the registry; 212 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with diminished ovarian reserve
  • \<3 oocytes collected in previous cycle (with anti-mullerian hormone \<0.5 ng/mL and/or antral follicle count \<5)
  • Cycles stimulated with flexible antagonist protocol
  • Cycles triggered with recombinant hCG
  • Fresh transfer cycles
  • Patients with \<40 years of age
  • BMI \<30 kg/m2

Exclusion criteria

Exclusion Criteria:

  • Preimplantation genetic testing
  • Azospermia
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
34 participants (estimated)

Study arms

  • No intervention
    Control ovary
  • Experimental
    Punctured ovary

    Procedure: Ovarian puncture

Interventions

  • ProcedureOvarian puncture

    One side ovary of each patient included in the study, will be punctured 10 times under trans-vaginal ultrasound guidance with 17 gauge ovarian pick up needle, 1 month before the scheduled IVF cycle. Control group will be the other side ovary for each patient. Number of ≥ 14 mm follicle and collected oocytes will be compared.

06

What researchers measure

Primary outcomes

  1. Number of ≥14 mm follicle

    Number of ≥14 mm follicle on the trigger day

    Time frame: 4 month after intervention as a response to ovarian stimulation

  2. Antral follicle count

    Antral follicle count

    Time frame: 4 month after intervention on the second/third day of menstrual cycle

Secondary outcomes

  1. Number of collected oocytes

    Number of collected oocytes on the oocyte pick-up day

    Time frame: 4 month after intervention as a response to ovarian stimulation

07

Study locations

1 of 1 sites recruiting
  • Hacettepe UniversityHacettepe University School of Medicine, Department of Ob/Gyn
    Ankara, 06100, Turkey
    • Sezcan Mumusoglu, Assoc. Prof. · Contact · sezcanmumusoglu@gmail.com · +905326404673
    • Gurkan Bozdag, Prof. · Principal investigator
    • Sezcan Mumusoglu, Assoc. Prof. · Principal investigator
    • Esra Uyanık, MD · Sub investigator
    • Haldun Murat Erden, MD · Sub investigator
    Recruiting
08

References and documents

Publications

  • De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet. 2010 Sep 11;376(9744):911-21. doi: 10.1016/S0140-6736(10)60355-8. Epub 2010 Aug 11. PubMed 20708256 ↗
  • Torrealday S, Kodaman P, Pal L. Premature Ovarian Insufficiency - an update on recent advances in understanding and management. F1000Res. 2017 Nov 29;6:2069. doi: 10.12688/f1000research.11948.1. eCollection 2017. PubMed 29225794 ↗
  • Ferraretti AP, Gianaroli L. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision? Hum Reprod. 2014 Sep;29(9):1842-5. doi: 10.1093/humrep/deu139. Epub 2014 Jul 9. PubMed 25008235 ↗
  • Bachelot A, Nicolas C, Bidet M, Dulon J, Leban M, Golmard JL, Polak M, Touraine P. Long-term outcome of ovarian function in women with intermittent premature ovarian insufficiency. Clin Endocrinol (Oxf). 2017 Feb;86(2):223-228. doi: 10.1111/cen.13105. Epub 2016 Jun 14. PubMed 27177971 ↗
  • Chen X, Chen SL, Ye DS, Liu YD, He YX, Tian XL, Xu LJ, Tao T. Retrospective analysis of reproductive outcomes in women with primary ovarian insufficiency showing intermittent follicular development. Reprod Biomed Online. 2016 Apr;32(4):427-33. doi: 10.1016/j.rbmo.2015.12.011. Epub 2016 Jan 14. PubMed 26825246 ↗
  • Kawamura K, Kawamura N, Hsueh AJ. Activation of dormant follicles: a new treatment for premature ovarian failure? Curr Opin Obstet Gynecol. 2016 Jun;28(3):217-22. doi: 10.1097/GCO.0000000000000268. PubMed 27022685 ↗
  • Zhang X, Han T, Yan L, Jiao X, Qin Y, Chen ZJ. Resumption of Ovarian Function After Ovarian Biopsy/Scratch in Patients With Premature Ovarian Insufficiency. Reprod Sci. 2019 Feb;26(2):207-213. doi: 10.1177/1933719118818906. Epub 2018 Dec 12. PubMed 30541396 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04608695
Lead sponsor
Hacettepe University
Responsible party
Sezcan Mumusoglu (Associate Professor, Hacettepe University) — Principal investigator
First posted
Oct 29, 2020
Start date
Jul 1, 2020
Primary completion
Jul 1, 2023 (estimated)
Completion
Sep 1, 2023 (estimated)
Last update
Sep 21, 2022

Study contacts

Sezcan Mumusoglu, Assoc. Prof.
Contact
sezcanmumusoglu@gmail.com
+905326404673
Sezcan Mumusoğlu, Assoc. Prof.
principal investigator · Hacettepe University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion